Clinical trialNCT02043587TerminatedPhase 2Interventional

Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

SponsorUniversity of California, San DiegoEnrollment31Acute Lymphocytic LeukemiaAdult Lymphoblastic Lymphoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

James K Mangan, MD, PhD
UC San Diego, Division of Blood and Marrow Transplantation
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ucsd, Division of Blood and Marrow Transplantation, Moores Cancer Center
La Jolla, California, United States
Hematological Malignancies/stem Cell Transplantation Unit, David Geffen School of Medicine at Ucla
Los Angeles, California, United States
University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
Ucsf Comprehensive Cancer Center
San Francisco, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jan 2014
Primary completion: 14 Apr 2022
Completion: 14 Apr 2022
Last update posted: 2 May 2022
Registered enrollment: 31
Registry id: NCT02043587

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.